Pentoxifylline or theophylline use in hospitalized COVID ‐19 patients requiring oxygen support

ConclusionIn this retrospective study, theophylline and pentoxifylline were associated with an increase in ROX score and nominal decreases in CRP and mortality. Treatment was safe with few adverse reactions documented. We believe that this study could the basis for randomized ‐controlled trials to further explore these drugs’ role in COVID‐19.

Source: The Clinical Respiratory Journal - March 28, 2021 Category: Respiratory Medicine Authors: Geoffrey C. Wall, Hayden L. Smith, Matthew W. Trump, Jason D. Mohr, Samuel P. DuMontier, Becca L. Sabates, Iaswarya Ganapathiraju, Tim J. Kable Tags: BRIEF REPORT Source Type: research